Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies

ABSTRACT Hepatitis C virus (HCV) infection is dependent on at least three coreceptors: CD81, scavenger receptor BI (SR-BI), and claudin-1. The mechanism of how these molecules coordinate HCV entry is unknown. In this study we demonstrate that a cell culture-adapted JFH-1 mutant, with an amino acid change in E2 at position 451 (G451R), has a reduced dependency on SR-BI. This altered receptor dependency is accompanied by an increased sensitivity to neutralization by soluble CD81 and enhanced binding of recombinant E2 to cell surface-expressed and soluble CD81. Fractionation of HCV by density gradient centrifugation allows the analysis of particle-lipoprotein associations. The cell culture-adapted mutation alters the relationship between particle density and infectivity, with the peak infectivity occurring at higher density than the parental virus. No association was observed between particle density and SR-BI or CD81 coreceptor dependence. JFH-1 G451R is highly sensitive to neutralization by gp-specific antibodies, suggesting increased epitope exposure at the virion surface. Finally, an association was observed between JFH-1 particle density and sensitivity to neutralizing antibodies (NAbs), suggesting that lipoprotein association reduces the sensitivity of particles to NAbs. In summary, mutation of E2 at position 451 alters the relationship between particle density and infectivity, disrupts coreceptor dependence, and increases virion sensitivity to receptor mimics and NAbs. Our data suggest that a balanced interplay between HCV particles, lipoprotein components, and viral receptors allows the evasion of host immune responses.

[1]  J. Sodroski,et al.  Identification and characterization of monoclonal antibodies specific for polymorphic antigenic determinants within the V2 region of the human immunodeficiency virus type 1 envelope glycoprotein , 1995, Journal of virology.

[2]  B. Bartosch,et al.  Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1–E2 Envelope Protein Complexes , 2003, The Journal of experimental medicine.

[3]  D. Adams,et al.  Immunopathology and Infectious Diseases Expression of DC-SIGN and DC-SIGNR on Human Sinusoidal Endothelium A Role for Capturing Hepatitis C Virus Particles , 2006 .

[4]  S. Wünschmann,et al.  Characterization of Hepatitis C Virus (HCV) and HCV E2 Interactions with CD81 and the Low-Density Lipoprotein Receptor , 2000, Journal of Virology.

[5]  D. Lavillette,et al.  Characterization of host‐range and cell entry properties of the major genotypes and subtypes of hepatitis C virus , 2005, Hepatology.

[6]  F. Chisari,et al.  Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion , 2007, Journal of Virology.

[7]  Ralf Bartenschlager,et al.  High Density Lipoprotein Inhibits Hepatitis C Virus-neutralizing Antibodies by Stimulating Cell Entry via Activation of the Scavenger Receptor BI* , 2006, Journal of Biological Chemistry.

[8]  M. Kieny,et al.  Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis. , 2006, The Journal of general virology.

[9]  R. Bartenschlager,et al.  Production of infectious hepatitis C virus in tissue culture from a cloned viral genome , 2005, Nature Medicine.

[10]  M. Gale,et al.  Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins , 2007, Proceedings of the National Academy of Sciences.

[11]  A. Maerz,et al.  A Conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr Motif in Hepatitis C Virus Glycoprotein E2 Is a Determinant of CD81 Binding and Viral Entry , 2006, Journal of Virology.

[12]  C. Rice,et al.  Hepatitis C Virus Entry* , 2008, Journal of Biological Chemistry.

[13]  Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein , 2008, The Journal of general virology.

[14]  H. Drummer,et al.  Determinants of CD81 dimerization and interaction with hepatitis C virus glycoprotein E2. , 2005, Biochemical and Biophysical Research Communications - BBRC.

[15]  Q. Sattentau,et al.  Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding , 1993, Journal of virology.

[16]  E. Blanchard,et al.  Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis , 2006, Journal of Virology.

[17]  Z. Keck,et al.  Immunogenic and Functional Organization of Hepatitis C Virus (HCV) Glycoprotein E2 on Infectious HCV Virions , 2006, Journal of Virology.

[18]  R. Thomssen,et al.  Association of hepatitis C virus in human sera with beta-lipoprotein. , 1992, Medical microbiology and immunology.

[19]  L. Seeff,et al.  Natural history of hepatitis C , 1997, Hepatology.

[20]  A. Tarr,et al.  Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding , 2006, Journal of Virology.

[21]  S. Levy,et al.  CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. , 1998, Annual review of immunology.

[22]  R. Doms,et al.  Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR , 2003, Journal of Virology.

[23]  C. Cheng‐Mayer,et al.  Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Olga Kalinina,et al.  Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection , 2007, Cellular microbiology.

[25]  T. Dragic,et al.  Hepatitis C Virus Entry Requires a Critical Postinternalization Step and Delivery to Early Endosomes via Clathrin-Coated Vesicles , 2006, Journal of Virology.

[26]  R. Thomssen,et al.  Association of hepatitis C virus in human sera with β-lipoprotein , 2004, Medical Microbiology and Immunology.

[27]  James S. Owen,et al.  Scavenger Receptor BI and BII Expression Levels Modulate Hepatitis C Virus Infectivity , 2007, Journal of Virology.

[28]  T L Hoffman,et al.  Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[29]  William C. Olson,et al.  CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5 , 1996, Nature.

[30]  Jean Dubuisson,et al.  High Density Lipoproteins Facilitate Hepatitis C Virus Entry through the Scavenger Receptor Class B Type I* , 2005, Journal of Biological Chemistry.

[31]  R. W. Mccollum The natural history of hepatitis. , 1969, Bulletin of the New York Academy of Medicine.

[32]  O. Schwartz,et al.  DC-SIGN and L-SIGN Are High Affinity Binding Receptors for Hepatitis C Virus Glycoprotein E2* , 2003, Journal of Biological Chemistry.

[33]  L. Corey,et al.  Use of the MagNA Pure LC Automated Nucleic Acid Extraction System followed by Real-Time Reverse Transcription-PCR for Ultrasensitive Quantitation of Hepatitis C Virus RNA , 2004, Journal of Clinical Microbiology.

[34]  D. Ho,et al.  Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner , 2004, Journal of Virology.

[35]  R. Cortese,et al.  The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus , 2002, The EMBO journal.

[36]  Joseph Sodroski,et al.  CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5 , 1996, Nature.

[37]  R. Bartenschlager,et al.  The lipid droplet is an important organelle for hepatitis C virus production , 2007, Nature Cell Biology.

[38]  Christopher T. Jones,et al.  Diverse CD81 Proteins Support Hepatitis C Virus Infection , 2006, Journal of Virology.

[39]  A. Burt,et al.  Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients , 2006, Journal of Virology.

[40]  Y. Tang,et al.  Development of a ssRNA internal control template reagent for a multiplex RT-PCR to detect turkey astroviruses. , 2005, Journal of virological methods.

[41]  A. Thiele,et al.  Density heterogeneities of hepatitis C virus in human sera due to the binding of β-lipoproteins and immunoglobulins , 1993, Medical Microbiology and Immunology.

[42]  J. McKeating,et al.  Effect of Cell Polarization on Hepatitis C Virus Entry , 2007, Journal of Virology.

[43]  D. Silver SR-BI and Protein-Protein Interactions in Hepatic High Density Lipoprotein Metabolism , 2004, Reviews in Endocrine and Metabolic Disorders.

[44]  J. Dubuisson,et al.  Early steps of the hepatitis C virus life cycle , 2008, Cellular microbiology.

[45]  S. Lemon,et al.  Definition of a Conserved Immunodominant Domain on Hepatitis C Virus E2 Glycoprotein by Neutralizing Human Monoclonal Antibodies , 2008, Journal of Virology.

[46]  D. Harats,et al.  The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus. , 2007, Journal of hepatology.

[47]  M. Houghton,et al.  Binding of hepatitis C virus to CD81. , 1998, Science.

[48]  B. Chesebro,et al.  Effects of CCR5 and CD4 Cell Surface Concentrations on Infections by Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.

[49]  Christopher T. Jones,et al.  University of Birmingham Time-and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry , 2006 .

[50]  S. Emerson,et al.  Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus , 2008, Proceedings of the National Academy of Sciences.

[51]  P. André,et al.  Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles , 2002, Journal of Virology.

[52]  B. Manicassamy,et al.  Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: Putative CD81 binding region 1 is not involved in CD81 binding , 2008, Virology Journal.

[53]  C. Blish,et al.  Enhancing Exposure of HIV-1 Neutralization Epitopes through Mutations in gp41 , 2008, PLoS medicine.

[54]  J. Sodroski,et al.  The Level of CD4 Expression Limits Infection of Primary Rhesus Monkey Macrophages by a T-Tropic Simian Immunodeficiency Virus and Macrophagetropic Human Immunodeficiency Viruses , 2000, Journal of Virology.

[55]  Robert J. Linhardt,et al.  Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan SulfateInteraction , 2006, Journal of Virology.

[56]  Charles M. Rice,et al.  Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry , 2007, Nature.

[57]  R. Bartenschlager,et al.  Cell Culture Adaptation of Hepatitis C Virus and In Vivo Viability of an Adapted Variant , 2007, Journal of Virology.

[58]  R. Cortese,et al.  High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein , 2007, Journal of Virology.

[59]  F. Penin,et al.  An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies , 2005, Journal of Virology.

[60]  C. Rice,et al.  Oxidized low‐density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells , 2006, Hepatology.

[61]  C. Rice,et al.  Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[62]  F. Chisari,et al.  Persistent Hepatitis C Virus Infection In Vitro: Coevolution of Virus andHost , 2006, Journal of Virology.

[63]  D. Burton,et al.  Robust hepatitis C virus infection in vitro. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[64]  A. Burt,et al.  Characterization of the genome and structural proteins of hepatitis C virus resolved from infected human liver. , 2004, The Journal of general virology.

[65]  Robert J. Linhardt,et al.  Cellular Binding of Hepatitis C Virus Envelope Glycoprotein E2 Requires Cell Surface Heparan Sulfate* , 2003, Journal of Biological Chemistry.

[66]  J. Dubuisson,et al.  Serum-Derived Hepatitis C Virus Infection of Primary Human Hepatocytes Is Tetraspanin CD81 Dependent , 2007, Journal of Virology.

[67]  S. Sone,et al.  The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles , 2007, Journal of medical virology.

[68]  Toshiaki Maruyama,et al.  Complete Replication of Hepatitis C Virus in Cell Culture , 2005, Science.

[69]  P. Briand,et al.  Mutations in the env gene of human immunodeficiency virus type 1 NDK isolates and the use of African green monkey CXCR4 as a co-receptor in COS-7 cells. , 1999, The Journal of general virology.

[70]  J. Dubuisson,et al.  Characterization of Hepatitis C Virus E2 Glycoprotein Interaction with a Putative Cellular Receptor, CD81 , 1999, Journal of Virology.

[71]  Jieyun Jiang,et al.  Human Apolipoprotein E Is Required for Infectivity and Production of Hepatitis C Virus in Cell Culture , 2007, Journal of Virology.

[72]  B. Bartosch,et al.  C-type Lectins L-SIGN and DC-SIGN Capture and Transmit Infectious Hepatitis C Virus Pseudotype Particles* , 2004, Journal of Biological Chemistry.

[73]  H. Drummer,et al.  Identification of the Hepatitis C Virus E2 Glycoprotein Binding Site on the Large Extracellular Loop of CD81 , 2002, Journal of Virology.

[74]  Arvind H. Patel,et al.  Analysis of Antigenicity and Topology of E2 Glycoprotein Present on Recombinant Hepatitis C Virus-Like Particles , 2002, Journal of Virology.

[75]  S. Lemon,et al.  A Point Mutation Leading to Hepatitis C Virus Escape from Neutralization by a Monoclonal Antibody to a Conserved Conformational Epitope , 2008, Journal of Virology.

[76]  J. McKeating,et al.  Hepatitis C virus cell‐cell transmission in hepatoma cells in the presence of neutralizing antibodies , 2007, Hepatology.

[77]  Ursula Andréo,et al.  The interaction of natural hepatitis C virus with human scavenger receptor SR‐BI/Cla1 is mediated by ApoB‐containing lipoproteins , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[78]  M. Krieger,et al.  Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems. , 2001, The Journal of clinical investigation.

[79]  Charles M. Rice,et al.  Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication , 2002, Journal of Virology.

[80]  Ralf Bartenschlager,et al.  Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81 , 2007, Hepatology.

[81]  J. McKeating,et al.  Hepatitis C virus entry and neutralization. , 2008, Clinics in liver disease.

[82]  Thomas Baumert,et al.  Cooperativity between Cd81 and Scavenger Dependent on Cholesterol and Initiation of Hepatitis C Virus Infection Is , 2006 .